Live Breaking News & Updates on National Reimbursement Drug Listing

Stay updated with breaking news from National reimbursement drug listing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript

AMRN earnings call for the period ending March 31, 2024. ....

United Kingdom , United States , Jonathan Provoost , Paul Choi Goldman Sachs , Mark Marmur , Paul Choi , Roanna Ruiz Leerink , Steve Ketchum , Jessica Fye , Patrick Holt , Tom Reilly , Roanna Ruiz , American College Of Cardiology , European Patent Office , Uk High Court , Cantor Fitzgerald , Journal Of The American College Cardiology , Corporate Communications , American College Of Cardiology Annual Scientific Session , National Reimbursement Drug Listing , Amarin Corporation , High Court , Goldman Sachs , Amarin Plc , Risk Factors , Investor Relations ,

Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China

VASCEPA Approved by the National Medical Products Administration as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia EddingPharm Now. | June 1, 2023 ....

United Arab Emirates , New Jersey , United States , Rebecca Xu , Mark Marmur , Lisa Defrancesco , Steven Ketchum , European Union , Amarin Corporation , Environmental Sciences , Clinical Development , China National Medical Products Administration , Research Development , Drug Administration , Exchange Commission , National Medical Products Administration , World Heart Federation Fact Sheet , Cardiovascular Health , World Heart Federation , National Reimbursement Drug Listing , Committee Of The Report On Cardiovascular Health , Reduce Triglyceride Levels , Adult Patients , Severe Hypertriglyceridemia , Pharm Now Working Towards Preparing , Commercial Launch ,

Amarin Corporation plc: Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China

VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (= 500 mg/dL) ....

United Arab Emirates , New Jersey , United States , Lisa Defrancesco , Mark Marmur , Rebecca Xu , Steven Ketchum , Environmental Sciences , European Union , Drug Administration , Amarin Corporation , Clinical Development , Exchange Commission , World Heart Federation Fact Sheet , Research Development , National Medical Products Administration , Committee Of The Report On Cardiovascular Health , Cardiovascular Health , National Reimbursement Drug Listing , China National Medical Products Administration , World Heart Federation , Reduce Triglyceride Levels , Adult Patients , Severe Hypertriglyceridemia , Pharm Now Working Towards Preparing , Commercial Launch ,